Comment On: ``2026 Myeloma Treatment Guidelines of the Turkish Myeloma Study Group''
Clinical Lymphoma Myeloma and Leukemia · 2026-11 · 26 (11) · e1300-e1301
DOI: 10.1016/j.clml.2026.08.014 ↗Kurz gefasst
Leserbrief in der Zeitschrift Clinical Lymphoma Myeloma and Leukemia, 2026-11. Verfasst von Ugur Hatipoglu und 3 weiteren Autor:innen. Beteiligte Einrichtung: Ankara Oncology Training and Research Hospital, Hematology and Bone Marrow Transplant Unit, University Of Health Sciences, Ankara, Türkiye. Electroni…. Die Arbeit nennt 12 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Ankara Oncology Training and Research Hospital, Hematology and Bone Marrow Transplant Unit, University Of Health Sciences, Ankara, Türkiye. Electronic address: ugurugur2192@gmail.com.
- Ankara Oncology Training and Research Hospital, Hematology and Bone Marrow Transplant Unit, University Of Health Sciences, Ankara, Türkiye.
Zitieren
APA
Hatipoglu, U., Seyhan, M., Eminoğlu, H., & Dal, M. S. (2026). Comment On: ``2026 Myeloma Treatment Guidelines of the Turkish Myeloma Study Group''. Clinical Lymphoma Myeloma and Leukemia, 26(11), e1300-e1301. https://doi.org/10.1016/j.clml.2026.08.014
Vancouver
Hatipoglu U, Seyhan M, Eminoğlu H, Dal MS. Comment On: ``2026 Myeloma Treatment Guidelines of the Turkish Myeloma Study Group''. Clinical Lymphoma Myeloma and Leukemia. 2026;26(11):e1300-e1301. doi:10.1016/j.clml.2026.08.014
BibTeX
@article{Hatipoglu2026,
author = {Hatipoglu, Ugur and Seyhan, Mert and Eminoğlu, Hakan and Dal, Mehmet Sinan},
title = {Comment On: ``2026 Myeloma Treatment Guidelines of the Turkish Myeloma Study Group''},
journal = {Clinical Lymphoma Myeloma and Leukemia},
year = {2026},
volume = {26},
number = {11},
pages = {e1300--e1301},
doi = {10.1016/j.clml.2026.08.014}
}
EUVIMED